2m 2m 2m 2m 2m 2m 2m
Emergent BioSolu (EBS)
NYSE
$8.29$0.00 (0.00%)
Price as of Jun 15, 2026 7:40 PM EDT- $429.3MMarket Cap
- 32.85%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Emergent BioSolu (EBS)
$8.29$0.00 (0.00%)
EBS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.29 | ||
Change | -$0.03 (-0.36%) | ||
Open | $8.46 | ||
High | $8.49 | ||
Low | $8.23 | ||
Previous Close | $8.32 | ||
Volume | 688,726 | ||
30-Day Average Volume | 800,860 | ||
1-Week Change | 3.62% | ||
1-Month Change | 4.41% | ||
1-Year Change | 32.85% | ||
3-Year Change | 2.47% | ||
5-Year Change | -86.54% | ||
Fundamentals | |||
Shares Outstanding | 51.6M | ||
Total Assets | $1.3B | ||
Market Cap | $429.3M | ||
Enterprise Value | $842.6M | ||
Period: QTR TTM FY | |||
Revenue | $149.7M | ||
Net Income | $6.8M | ||
Free Cash Flow | -$36.2M | ||
EBIT | $13.4M | ||
EBITDA | $36.9M | ||
Net Working Capital | $488.9M | ||
EPS | $0.07 | ||
Enterprise Value/EBITDA | 23 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | 119 | ||
PEG | 1 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue